← Leaderboards
Val John Lowe
Mayo Clinic Rochester
$2,249,674
Attributed
$4,499,348
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $946.2K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,499,348 · 3
By mechanism
R01$4,062,098 · 2
R21$437,250 · 1
Top collaborators
- Melissa Erin Murray5 shared
- Karunya Kumar Kandimalla4 shared
- James L. Kirkland2 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Jan M. Van Deursen$15,959,798
- James L. Kirkland$27,302,366
- Ozgur Ogut$1,673,864
- Marissa Joy Schafer$6,150,867
- Robert John Pignolo$5,555,703
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseasePharmaceutical PreparationsUptakeSignal TransductionInnovationS Disease PathologyPathologicAgingPathologyPositron-Emission TomographyAutopsyIn VivoDementiaStrokeDiabetes MellitusImagePhenotypePathway InteractionsMetabolicMouse ModelImaging ModalityAmyloid PathologyHigh Risk
Grant awards (11)
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$478,190
R01 · FY2025 · NS
Tau PET/CT for Early Detection of Alzheimerâs Disease Pathology$388,583
R01 · FY2025 · AG · contact PI
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$529,773
R01 · FY2024 · NS
Tau PET/CT for Early Detection of Alzheimerâs Disease Pathology$396,514
R01 · FY2024 · AG · contact PI
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$529,773
R01 · FY2023 · NS
Tau PET/CT for Early Detection of Alzheimerâs Disease Pathology$396,514
R01 · FY2023 · AG · contact PI
Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier$549,723
R01 · FY2022 · NS
Tau PET/CT for Early Detection of Alzheimerâs Disease Pathology$396,514
R01 · FY2022 · AG · contact PI
Tau PET/CT for Early Detection of Alzheimerâs Disease Pathology$396,514
R01 · FY2021 · AG · contact PI
Imaging for Cellular Senescence$238,500
R21 · FY2016 · AG
Imaging for Cellular Senescence$198,750
R21 · FY2015 · AG